Deere & Co: Form 10-Q for the period ended Jul 31, 2022
Filed with the SEC on Sep 1, 2022 and accepted by EDGAR at Sep 1, 2022, 13:53 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2022-07-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2022-05-02 to 2022-07-31 | $14.10bn | us-gaap:Revenues |
| Revenue | 9 months2021-11-01 to 2022-07-31 | $37.04bn | us-gaap:Revenues |
| Research and development | 3 months2022-05-02 to 2022-07-31 | $481.0m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 9 months2021-11-01 to 2022-07-31 | $1.34bn | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months2022-05-02 to 2022-07-31 | $959.0m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 9 months2021-11-01 to 2022-07-31 | $2.67bn | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2022-05-02 to 2022-07-31 | $2.65bn | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2021-11-01 to 2022-07-31 | $6.55bn | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2022-05-02 to 2022-07-31 | $296.0m | us-gaap:InterestExpense |
| Interest expense | 9 months2021-11-01 to 2022-07-31 | $713.0m | us-gaap:InterestExpense |
| Income tax | 3 months2022-05-02 to 2022-07-31 | $654.0m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months2021-11-01 to 2022-07-31 | $1.36bn | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2022-05-02 to 2022-07-31 | $1.88bn | us-gaap:NetIncomeLoss |
| Net income | 9 months2021-11-01 to 2022-07-31 | $4.88bn | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2022-05-02 to 2022-07-31 | $6.16 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months2021-11-01 to 2022-07-31 | $15.88 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2022-05-02 to 2022-07-31 | $6.20 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months2021-11-01 to 2022-07-31 | $15.97 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2022-05-02 to 2022-07-31 | 305,700,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months2021-11-01 to 2022-07-31 | 307,700,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months2021-11-01 to 2022-07-31 | $418.0m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months2021-11-01 to 2022-07-31 | $596.0m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 9 months2021-11-01 to 2022-07-31 | $971.0m | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 9 months2021-11-01 to 2022-07-31 | $2.48bn | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2022-07-31 | $4.36bn | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Total assets | At period end2022-07-31 | $86.82bn | us-gaap:Assets |
| Total liabilities | At period end2022-07-31 | $67.69bn | us-gaap:Liabilities |
| Current portion of debt | At period end2022-07-31 | $14.18bn | us-gaap:DebtCurrent |
| Shareholders' equity | At period end2022-07-31 | $19.03bn | us-gaap:StockholdersEquity |
| Shares outstanding | At period end2022-07-31 | 301,819,630 shares | dei:EntityCommonStockSharesOutstanding |
Source: SEC EDGAR, the filing index for accession 0001558370-22-014113. Last ingested by Listed: Nov 4, 2026, 09:50 ET. Listed shows no prices and gives no investment advice.